ACST - Acasti Pharma Inc.

QQQ $ 441.71 $ 1.04 (0.24 %)

DIA $ 395.04 $ 1.18 (0.3 %)

SPY $ 520.76 $ 0.67 (0.13 %)

TLT $ 90.14 $ -0.51 (-0.56 %)

GLD $ 218.73 $ 1.76 (0.81 %)

Previous Close

$ 2.76

Open

$ 2.82

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 2.82 - $ 2.82

52 Week Range

$ 1.72 - $ 3.84

Volume

4,308

Average Volume

Market Cap

25.94M

Beta (5Y Monthly)

$ 1.48

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	02-12-2024	12-31-2023	10-Q
2	11-13-2023	09-30-2023	10-Q
3	08-11-2023	06-30-2023	10-Q
4	06-23-2023	03-31-2023	10-K
5	02-14-2023	12-31-2022	10-Q
6	11-14-2022	09-30-2022	10-Q
7	08-11-2022	06-30-2022	10-Q
8	06-21-2022	03-31-2022	10-K
9	02-14-2022	12-31-2021	10-Q
10	11-10-2021	09-30-2021	10-Q
11	08-12-2021	06-30-2021	10-Q
12	06-22-2021	03-31-2021	10-K
13	02-09-2021	12-31-2020	10-Q
14	11-16-2020	09-30-2020	10-Q
15	08-13-2020	06-30-2020	10-Q
16	06-29-2020	03-31-2020	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Acasti Pharma Q3 EPS $(0.21) Up From $(0.5...
02/12/2024 13:12:22

Acasti Pharma (NASDAQ:ACST) reported quarterly losses of $(0.21) per share. This is a 59.62 percent increase over losses of $(0...

Craig-Hallum Initiates Coverage On Acasti ...
02/07/2024 14:10:43

Craig-Hallum analyst Chase Knickerbocker initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Buy rating and announces P...

Acasti Announces Poster Detailing GTX-104 ...
02/01/2024 13:39:22

The poster, Safety and Tolerability of Intravenous Versus Enteral Nimodipine in Patients with Aneurysmal Subarachnoid Hemorrhag...

why-keycorp-shares-are-trading-lower-by-over-5-here-are-other-stocks-moving-in-thursdays-mid-day-session

Why KeyCorp Shares Are Trading Lower By Ov...
01/18/2024 18:08:48

Shares of KeyCorp (NYSE: KEY) moved lower during Thursday’s session after the company reported fourth-quarter financial results...

Acasti Announces Dosing Of First Patient I...
10/23/2023 12:05:38

Acasti Pharma Inc Files For Shelf Of Up To...
10/06/2023 20:36:42

-SEC Filing

Acasti Pharma 10% Owner Vimal Kavuru Repo...
09/28/2023 09:22:52

why-td-synnex-shares-are-trading-lower-by-over-5-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Why TD SYNNEX Shares Are Trading Lower By ...
09/26/2023 16:56:35

Gainers Soleno Therapeutics, Inc. (NASDAQ: SLNO) shares jumped 318.5% to $18.54 after the company released top-line results...

why-acasti-pharma-acst-stock-is-exploding-higher

Why Acasti Pharma (ACST) Stock Is Explodin...
09/26/2023 14:57:29

Acasti Pharma Inc (NASDAQ: ACST) shares are trading higher by 34.3% to $2.35 Tuesday morning after the company announced $7.5 m...

Acasti Announces $7.5M Private Placement E...
09/26/2023 12:01:35

Acasti To Present GTX-104 Pharmacokinetic ...
08/09/2023 21:23:29

Acasti Pharma Inc. (NASDAQ:ACST) ("Acasti" or the "Company"), a late-stage, biopharma company advancing GTX-104...

Acasti Announces WuXi Clinical As CRO To C...
07/10/2023 13:08:46

STRIVE-ON is a pivotal Phase 3 trial of GTX-104 to evaluate its comparable safety and tolerability profile relative to oral nim...

Acasti Pharma Announces 1-For-6 Reverse St...
07/07/2023 12:03:17

Acasti Pharma Inc. ("Acasti" or the "Company") (NASDAQ:ACST), a late-stage, biopharma company advancing GTX-104...

why-1847-holdings-shares-are-trading-lower-by-around-31-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Why 1847 Holdings Shares Are Trading Lower...
07/05/2023 17:28:59

Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) shares surged 87% to $11.78 after the company said the initial data from ...

Acasti Announces Alignment With FDA On GTX...
07/05/2023 13:03:26

UPDATE: Acasti Pharma Q4 Adj EPS $(0.11), ...
06/23/2023 12:33:42

Acasti Pharma (NASDAQ:ACST) reported quarterly losses of $(0.11) per share which met the analyst consensus estimate. This is a ...

Recap: Acasti Pharma Q4 Earnings
06/23/2023 12:20:07

Acasti Pharma Q4 Adj EPS $(0.11), Inline, ...
06/23/2023 11:47:01

Acasti Pharma (NASDAQ: ACST) reported quarterly losses of $(0.11) per share which met the analyst consensus estimate. This is a...

FDA Has Allowed Acasti Pharma To Proceed W...
04/04/2023 12:09:07

The FDA concurred with the suitability of the 505(b)(2) regulatory pathway with the selected Reference Listed Drug (RLD) Nimoto...

EF Hutton Reiterates Buy on Acasti Pharma,...
02/15/2023 12:02:38

EF Hutton analyst Constantine Davides reiterates Acasti Pharma (NASDAQ:ACST) with a Buy and maintains $2.5 price target.